• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 INCA 评分对出院后 1 年内心力衰竭再入院进行分析和预测。

Analysis and prediction of readmissions for heart failure in the first year after discharge with INCA score.

机构信息

PhD Programme in Economics (DEcIDE), International Doctorate School of the National University of Distance Education (EIDUNED), 28015, Madrid, Spain.

Research Unit of Don Benito-Villanueva de la Serena Health Area, 06700, Villanueva de la Serena, Spain.

出版信息

Sci Rep. 2023 Dec 18;13(1):22477. doi: 10.1038/s41598-023-49390-w.

DOI:10.1038/s41598-023-49390-w
PMID:38110472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10728208/
Abstract

To determine the readmissions trends and the comorbidities of patients with heart failure that most influence hospital readmission rates. Heart failure (HF) is one of the most prevalent health problems as it causes loss of quality of life and increased health-care costs. Its prevalence increases with age and is a major cause of re-hospitalisation within 30 days after discharge. INCA study had observational and ambispective design, including 4,959 patients from 2000 to 2019, with main diagnosis of HF in Extremadura (Spain). The variables examined were collected from discharge reports. To develop the readmission index, capable of discriminating the population with higher probability of re-hospitalisation, a Competing-risk model was generated. Readmission rate have increased over the period under investigation. The main predictors of readmission were: age, diabetes mellitus, presence of neoplasia, HF without previous hospitalisation, atrial fibrillation, anaemia, previous myocardial infarction, obstructive pulmonary disease (COPD) and chronic kidney disease (CKD). These variables were assigned values with balanced weights, our INCA index showed that the population with values greater than 2 for men and women were more likely to be re-admitted. Previous HF without hospital admission, CKD, and COPD appear to have the greatest effect on readmission. Our index allowed us to identify patients with different risks of readmission.

摘要

为了确定心力衰竭患者再入院的趋势和影响住院再入院率的主要合并症。心力衰竭(HF)是最常见的健康问题之一,因为它会导致生活质量下降和医疗保健费用增加。其患病率随年龄增长而增加,是出院后 30 天内再次住院的主要原因。INCA 研究采用观察性和前瞻性设计,纳入了 2000 年至 2019 年来自西班牙埃斯特雷马杜拉的 4959 名主要诊断为心力衰竭的患者。检查的变量从出院报告中收集。为了开发能够区分再入院概率较高人群的再入院指数,生成了竞争风险模型。在此期间,再入院率有所增加。再入院的主要预测因素是:年龄、糖尿病、肿瘤存在、无既往住院史的心力衰竭、心房颤动、贫血、既往心肌梗死、阻塞性肺疾病(COPD)和慢性肾脏病(CKD)。这些变量被赋予平衡权重的值,我们的 INCA 指数表明,男性和女性值大于 2 的人群更有可能再次入院。既往无住院史的心力衰竭、CKD 和 COPD 似乎对再入院的影响最大。我们的指数能够识别具有不同再入院风险的患者。

相似文献

1
Analysis and prediction of readmissions for heart failure in the first year after discharge with INCA score.采用 INCA 评分对出院后 1 年内心力衰竭再入院进行分析和预测。
Sci Rep. 2023 Dec 18;13(1):22477. doi: 10.1038/s41598-023-49390-w.
2
Effect of Early Follow-Up After Hospital Discharge on Outcomes in Patients With Heart Failure or Chronic Obstructive Pulmonary Disease: A Systematic Review.出院后早期随访对心力衰竭或慢性阻塞性肺疾病患者预后的影响:一项系统评价
Ont Health Technol Assess Ser. 2017 May 25;17(8):1-37. eCollection 2017.
3
High Risk of Readmission After THA Regardless of Functional Status in Patients Discharged to Skilled Nursing Facility.入住专业护理机构的患者,无论功能状态如何,全髋关节置换术后再入院风险均高。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1185-1192. doi: 10.1097/CORR.0000000000002950. Epub 2024 Jan 16.
4
Frailty Is Associated With Increased 30-day Readmissions and Costs After Total Shoulder Arthroplasty.虚弱与全肩关节置换术后30天再入院率及费用增加相关。
Clin Orthop Relat Res. 2025 Apr 10. doi: 10.1097/CORR.0000000000003461.
5
Pre-discharge factors predicting readmissions of psychiatric patients: a systematic review of the literature.预测精神科患者再入院的出院前因素:文献系统综述
BMC Psychiatry. 2016 Dec 16;16(1):449. doi: 10.1186/s12888-016-1114-0.
6
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.中重度慢性阻塞性肺疾病(COPD)患者的支持性自我管理:证据综合与经济分析
Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360.
7
Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.近期心力衰竭出院患者的家庭远程监测或结构化电话支持计划:系统评价和经济评估。
Health Technol Assess. 2013 Aug;17(32):1-207, v-vi. doi: 10.3310/hta17320.
8
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后的肺康复治疗。
Cochrane Database Syst Rev. 2016 Dec 8;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4.
9
Hospital Readmissions Among People With Sickle Cell Disease.镰状细胞病患者的医院再入院情况。
JAMA Netw Open. 2025 Jun 2;8(6):e2517974. doi: 10.1001/jamanetworkopen.2025.17974.
10
Causes for 30-day readmissions and accuracy of the LACE index in regional Victoria, Australia.澳大利亚维多利亚地区 30 天再入院的原因及 LACE 指数的准确性。
Intern Med J. 2024 Jun;54(6):951-960. doi: 10.1111/imj.16324. Epub 2024 Jan 2.

引用本文的文献

1
Limited predictive value of traditional comorbidities for readmission in acute decompensated heart failure.传统合并症对急性失代偿性心力衰竭再入院的预测价值有限。
PLoS One. 2025 Aug 6;20(8):e0329829. doi: 10.1371/journal.pone.0329829. eCollection 2025.
2
Wireless and Battery-Free Sensor for Interstitial Fluid Pressure Monitoring.无线和电池免供的间质液压力监测传感器。
Sensors (Basel). 2024 Jul 9;24(14):4429. doi: 10.3390/s24144429.

本文引用的文献

1
[Clinical and prognostic profile evolution of patients discharged from hospital due to heart failure in the first two decades of the 21st century. The INCA-Ex Registry].[21世纪前二十年因心力衰竭出院患者的临床及预后特征演变。INCA-Ex注册研究]
Aten Primaria. 2022 Jul;54(7):102357. doi: 10.1016/j.aprim.2022.102357. Epub 2022 May 13.
2
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.基于生物标志物的糖尿病患者心力衰竭住院风险评分。
Diabetes Care. 2021 Nov;44(11):2573-2581. doi: 10.2337/dc21-1170. Epub 2021 Sep 17.
3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
4
Hospital readmissions of patients with heart failure from real world: timing and associated risk factors.现实世界中心力衰竭患者的医院再入院情况:时间及相关危险因素。
ESC Heart Fail. 2021 Apr;8(2):1388-1397. doi: 10.1002/ehf2.13221. Epub 2021 Feb 17.
5
Readmission and mortality among heart failure patients with history of hypertension in a statewide database.在全州范围内的数据库中,有高血压病史的心力衰竭患者的再入院率和死亡率。
J Clin Hypertens (Greenwich). 2020 Jul;22(7):1263-1274. doi: 10.1111/jch.13918. Epub 2020 Jul 7.
6
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.恩格列净治疗心力衰竭的心血管和肾脏结局。
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
7
Epidemiology of heart failure.心力衰竭的流行病学。
Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1.
8
Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis.合并 COPD 和心力衰竭患者的住院和死亡率:系统评价和荟萃分析。
Respir Res. 2020 Feb 14;21(1):54. doi: 10.1186/s12931-020-1312-7.
9
Clinical and Socioeconomic Predictors of Heart Failure Readmissions: A Review of Contemporary Literature.临床和社会经济学因素对心力衰竭再入院的预测:当代文献回顾。
Mayo Clin Proc. 2019 Jul;94(7):1304-1320. doi: 10.1016/j.mayocp.2019.01.017.
10
Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.慢性阻塞性肺疾病对急性心力衰竭住院后再入院的影响:一项具有全国代表性的美国队列研究。
Int J Cardiol. 2019 Sep 1;290:113-118. doi: 10.1016/j.ijcard.2019.04.087. Epub 2019 Apr 30.